198 related articles for article (PubMed ID: 11589682)
1. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
[TBL] [Abstract][Full Text] [Related]
2. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
[TBL] [Abstract][Full Text] [Related]
3. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
4. Third-Generation Thyrotropin Receptor Antibody (TRAb) assay for predicting neonatal thyroid dysfunction in pregnant women with Graves' disease.
Priyanka R; Sridhar S; Sumathi B; Jeyaraj AR; Natarajan V; Subbiah E; Raghavan KS; Sangumani J
Endocrine; 2024 May; 84(2):500-508. PubMed ID: 37861945
[TBL] [Abstract][Full Text] [Related]
5. Thyroid stimulating hormone receptor antibody levels in Singaporean patients with autoimmune thyroid disease.
Khoo DH; Fok AC; Tan CE; Koh LK; Lim SC; Eng PH; Ho SC
Ann Acad Med Singap; 1997 Jul; 26(4):435-8. PubMed ID: 9395805
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
8. [TSH anti-receptor antibodies in Graves' disease].
Sérgio MR; Godinho C; Guerra L; Agapito A; Fonseca F; Costa C
Acta Med Port; 1996; 9(7-9):229-31. PubMed ID: 9005701
[TBL] [Abstract][Full Text] [Related]
9. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to the thyrotropin receptor.
Rees Smith B; McLachlan SM; Furmaniak J
Endocr Rev; 1988 Feb; 9(1):106-21. PubMed ID: 3286231
[TBL] [Abstract][Full Text] [Related]
11. Direct and quantitative measurement by immunoprecipitation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves' disease.
de Bruin TW; van der Heide D; Querido A; Krol MC
Clin Endocrinol (Oxf); 1984 Feb; 20(2):143-51. PubMed ID: 6325045
[TBL] [Abstract][Full Text] [Related]
12. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
13. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
[TBL] [Abstract][Full Text] [Related]
15. [TSH-receptor antibodies in thyroid diseases].
Hasse-Lazar K; Jarzab B; Podwiński A; Waler J; Sprzaczkowska K; Buła G; Skrzypek J
Pol Arch Med Wewn; 1997 Mar; 97(3):239-51. PubMed ID: 9333770
[TBL] [Abstract][Full Text] [Related]
16. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
[TBL] [Abstract][Full Text] [Related]
18. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.
Costagliola S; Morgenthaler NG; Hoermann R; Badenhoop K; Struck J; Freitag D; Poertl S; Weglöhner W; Hollidt JM; Quadbeck B; Dumont JE; Schumm-Draeger PM; Bergmann A; Mann K; Vassart G; Usadel KH
J Clin Endocrinol Metab; 1999 Jan; 84(1):90-7. PubMed ID: 9920067
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of TSH binding to chicken thyroid by some cases of LATS (long acting thyroid stimulator).
Nakajima Y; Ishida M; Kajita Y; Ura Y; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
Endocrinol Jpn; 1986 Jun; 33(3):375-83. PubMed ID: 3019653
[TBL] [Abstract][Full Text] [Related]
20. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]